Flowr Corp. - CEO, Darryl Brooker.
CEO, Darryl Brooker.
Source: Flowr Corp.
  • Flowr Corporation (FLWR) has sold common shares and intends to complete a private placement for total proceeds of over C$8 million
  • Under the securities purchase agreement, the company sold 33,400,000 units at $0.21 per unit for gross proceeds of $7,014,000
  • The company intends to complete a non-brokered private placement for aggregate gross proceeds of up to $1 million
  • It will use funds raised for debt repayments and for general corporate and working capital purposes
  • Flowr expects the offering and direct placement to close on or about July 20, 2021
  • The Flowr Corporation is a cannabis company with operations in Canada and the European Union
  • Flowr Corporation (FLWR) is down by 2.22 per cent and is currently trading at $0.22 per share

Flowr Corporation (FLWR) has sold common shares and intends to complete a private placement for total proceeds of over C$8 million.

Under the securities purchase agreement, the company sold 33,400,000 units at $0.21 per unit for gross proceeds of $7,014,000.

The company intends to complete a non-brokered private placement for aggregate gross proceeds of up to $1 million.

Each unit consists of one Flowr common share and one common share purchase warrant.

Each warrant entitles the holder to acquire one common share for $0.26 for 42 months following the closing of the offering.

Flowr will use the proceeds for partial repayment of outstanding debt and for general corporate and working capital purposes.

The company expects the offering and direct placement to close on or about July 20, 2021.

The Flowr Corporation is a cannabis company with operations in Canada and the European Union. 

Flowr Corporation (FLWR) is down by 2.22 per cent and is currently trading at $0.22 per share as of 11:38 am ET.

More From The Market Online
Cannabis Report across cannabis plants

StockTalk | Cannabis Report: Shake-ups

MediPharm Labs announced that chief executive officer, David Pidduck will step down from his role, effective January...

Buzz on the Bullboards: As Arctic tensions flare, investors eye three news‑making stocks

Global markets opened the week on edge as a fresh rift between Washington and key NATO...

MediPharm Labs announces CEO transition as David Pidduck steps down

MediPharm Labs (TSX:LABS) CEO David Pidduck will step down on January 23, 2026, and will remain on the Board to support the transition.
Cannabis leaves with Stock Talk and Cannabis Report labels

StockTalk | Cannabis Report: New digs

Cannabis e-commerce company Herbal Dispatch (CSE:HERB) grew sales by 38 per cent in 2025, marking its third-straight year...